Five years after the COVID-19 pandemic was declared, the protean syndrome dubbed long COVID continues to affect millions; Greenspan is dedicated to helping.
Data from the phase 2 VENTURE-Oral Dosing Trial of VK2735 is expected in the second half of the year, the company said.
Your daily dose of the clinical news you may have missed.
Data on use of lecanemab in real world clinical settings will come from a neurologic case series review and a retrospective chart review of long-term use, both in early AD.
Gepotidacin is the first new oral antibiotic for uncomplicated urinary tract infections in 30 years, offering an alternative amid rising antibiotic resistance.
More than one-third of study participants with TRD had failed to get relief from 4 or more antidepressants, calling treatment experiences a "trial and error" process.
ACC 2025: Black women and women in Southern states faced significantly higher rates of maternal mortality, according to a new study.
Rates of preventable deaths are rising in every US state, according to a new study, defying the country's top-ranking spending on health care.
Your daily dose of the clinical news you may have missed.
Adding a deadline to a mailed invitation for FIT colorectal cancer screening resulted in improved return rates, according to new research.